Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.04)
# 3,467
Out of 4,814 analysts
800
Total ratings
25.62%
Success rate
-18.7%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYTK Cytokinetics | Reiterates: Buy | $120 | $38.74 | +209.76% | 47 | Apr 15, 2025 | |
| GRI GRI Bio | Reiterates: Buy | $10 | $1.47 | +580.27% | 2 | Apr 14, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Neutral | $16 | $7.53 | +112.48% | 19 | Apr 10, 2025 | |
| XBIO Xenetic Biosciences | Reiterates: Neutral | n/a | $2.41 | - | 9 | Apr 9, 2025 | |
| CLNN Clene | Reiterates: Buy | $31 | $3.00 | +933.33% | 31 | Apr 8, 2025 | |
| PHGE BiomX | Reiterates: Buy | $21 | $0.53 | +3,830.38% | 14 | Apr 4, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $10 → $24 | $1.71 | +1,307.62% | 17 | Apr 4, 2025 | |
| KAPA Kairos Pharma | Initiates: Buy | $12 | $0.95 | +1,160.50% | 1 | Apr 3, 2025 | |
| BMEA Biomea Fusion | Reiterates: Buy | $40 | $1.65 | +2,331.61% | 29 | Apr 1, 2025 | |
| CALC CalciMedica | Reiterates: Buy | $16 | $1.53 | +945.75% | 11 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.19 | +236.13% | 28 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $26 | $2.76 | +841.62% | 12 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.47 | +975.27% | 15 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.51 | +689.73% | 21 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $20.94 | +396.66% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $13 | $1.06 | +1,126.42% | 30 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.74 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $23.50 | +334.04% | 30 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $8.09 | +357.35% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.00 | +1,505.30% | 27 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $77 | $10.77 | +614.95% | 21 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.72 | +539.53% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.28 | +3,475.26% | 2 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $3.09 | +1,032.69% | 7 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $4.03 | +297.02% | 19 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.1 | $4.04 | +1.61% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.42 | +2,052.08% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.75 | $1.83 | +214.21% | 21 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $16.49 | +245.66% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $18.14 | +341.14% | 31 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $221 | $167.32 | +32.08% | 27 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $2.97 | +979.26% | 27 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.80 | +589.66% | 25 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $11 | $8.96 | +22.77% | 8 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $0.23 | +2,919.84% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $5.09 | +312.57% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.52 | +1,219.78% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.14 | +514.04% | 14 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.94 | +1,188.66% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.20 | +583.37% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $105.00 | - | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.51 | +1,627.57% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $32 | $16.99 | +88.35% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.90 | +373.68% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.91 | +540.20% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.28 | +7,712.50% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.28 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.79 | +1,687.71% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.53 | +1,085.77% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.07 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $37.84 | -12.79% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $5.36 | +1,355.22% | 1 | Mar 24, 2017 |
Cytokinetics
Apr 15, 2025
Reiterates: Buy
Price Target: $120
Current: $38.74
Upside: +209.76%
GRI Bio
Apr 14, 2025
Reiterates: Buy
Price Target: $10
Current: $1.47
Upside: +580.27%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $7.53
Upside: +112.48%
Xenetic Biosciences
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.41
Upside: -
Clene
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $3.00
Upside: +933.33%
BiomX
Apr 4, 2025
Reiterates: Buy
Price Target: $21
Current: $0.53
Upside: +3,830.38%
Compass Therapeutics
Apr 4, 2025
Maintains: Buy
Price Target: $10 → $24
Current: $1.71
Upside: +1,307.62%
Kairos Pharma
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.95
Upside: +1,160.50%
Biomea Fusion
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $1.65
Upside: +2,331.61%
CalciMedica
Apr 1, 2025
Reiterates: Buy
Price Target: $16
Current: $1.53
Upside: +945.75%
Apr 1, 2025
Reiterates: Buy
Price Target: $4
Current: $1.19
Upside: +236.13%
Mar 31, 2025
Maintains: Buy
Price Target: $9 → $26
Current: $2.76
Upside: +841.62%
Mar 31, 2025
Reiterates: Buy
Price Target: $5
Current: $0.47
Upside: +975.27%
Mar 28, 2025
Reiterates: Buy
Price Target: $4
Current: $0.51
Upside: +689.73%
Mar 28, 2025
Reiterates: Buy
Price Target: $104
Current: $20.94
Upside: +396.66%
Mar 27, 2025
Maintains: Buy
Price Target: $21 → $13
Current: $1.06
Upside: +1,126.42%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.74
Upside: -
Mar 26, 2025
Reiterates: Buy
Price Target: $102
Current: $23.50
Upside: +334.04%
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $8.09
Upside: +357.35%
Mar 20, 2025
Reiterates: Buy
Price Target: $16
Current: $1.00
Upside: +1,505.30%
Mar 20, 2025
Reiterates: Buy
Price Target: $77
Current: $10.77
Upside: +614.95%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.72
Upside: +539.53%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.28
Upside: +3,475.26%
Mar 14, 2025
Reiterates: Buy
Price Target: $35
Current: $3.09
Upside: +1,032.69%
Mar 11, 2025
Reiterates: Buy
Price Target: $16
Current: $4.03
Upside: +297.02%
Mar 11, 2025
Downgrades: Neutral
Price Target: $4.1
Current: $4.04
Upside: +1.61%
Mar 11, 2025
Reiterates: Buy
Price Target: $9
Current: $0.42
Upside: +2,052.08%
Mar 6, 2025
Reiterates: Buy
Price Target: $5.75
Current: $1.83
Upside: +214.21%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $16.49
Upside: +245.66%
Mar 3, 2025
Reiterates: Buy
Price Target: $80
Current: $18.14
Upside: +341.14%
Feb 28, 2025
Reiterates: Buy
Price Target: $221
Current: $167.32
Upside: +32.08%
Feb 28, 2025
Reiterates: Buy
Price Target: $32
Current: $2.97
Upside: +979.26%
Feb 27, 2025
Reiterates: Buy
Price Target: $40
Current: $5.80
Upside: +589.66%
Feb 25, 2025
Maintains: Buy
Price Target: $21 → $11
Current: $8.96
Upside: +22.77%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $0.23
Upside: +2,919.84%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $5.09
Upside: +312.57%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.52
Upside: +1,219.78%
Dec 19, 2024
Reiterates: Buy
Price Target: $7
Current: $1.14
Upside: +514.04%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $1.94
Upside: +1,188.66%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.20
Upside: +583.37%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $105.00
Upside: -
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.51
Upside: +1,627.57%
Nov 11, 2024
Maintains: Buy
Price Target: $3 → $32
Current: $16.99
Upside: +88.35%
Nov 11, 2024
Reiterates: Buy
Price Target: $9
Current: $1.90
Upside: +373.68%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.91
Upside: +540.20%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.28
Upside: +7,712.50%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.28
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.79
Upside: +1,687.71%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.53
Upside: +1,085.77%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.07
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $37.84
Upside: -12.79%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $5.36
Upside: +1,355.22%